Search

Search Constraints

You searched for: Author/Creator Picco, Agnese

Search Results

11. P1‐393: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY). (1st July 2006)

12. P2‐188: Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european‐ADNI study. (1st July 2015)

13. P3‐101: CROSS‐SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E‐ADNI STUDY. (1st July 2014)

14. P3‐209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study. (1st July 2016)

15. P4‐190: 18FDG PET Predicts Time to Disease Milestones in a Naturalistic Population of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease. (1st July 2016)

16. Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers. Issue 12 (9th November 2017)

17. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Issue 8 (August 2017)

18. Test‐retest reliability of the default mode network in a multi‐centric fMRI study of healthy elderly: Effects of data‐driven physiological noise correction techniques. Issue 6 (17th March 2016)

19. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study. Issue 9 (3rd March 2017)